ICU Medical Beats Q3 2026 Estimates as Revenue Rises 4.4% to $560.4M

ICU Medical (ICUI) beat estimates for the third quarter of 2026 on both revenue and adjusted EPS. Revenue was $560.4 million, up 4.4% from a year earlier, above the $552.0 million estimate, and adjusted EPS was $2.44, up 20% from a year earlier, above the $2.14 estimate.

Shares were unchanged in after-hours trading as of 4:00 p.m. ET, to $167.65 from a $167.65 close.

Q3 2026 scorecard

By our calculation, revenue was $8.4 million above the estimate and adjusted EPS was $0.30 above it. The QoQ column compares with the previous quarter's revenue of $547.9 million and adjusted EPS of $2.37. The YoY column compares with $537.0 million and $2.03 in the same quarter a year earlier.

Track record

• EPS record. Adjusted EPS beat the estimate in 8 of the last 8 reports, including this one.
• Revenue record. Revenue beat the estimate in 7 of the last 8 reports.
• Revenue trend. Revenue over the last 5 reports, oldest first: $537.0 million, $535.9 million, $525.8 million, $547.9 million and $560.4 million.

What to watch

• Next-quarter estimates. Consensus calls for EPS of $2.22 and revenue of $561.0 million next quarter, based on 5 analysts.
• Revenue growth. Whether revenue keeps growing from a year earlier after this quarter's 4.4% increase to $560.4 million.
• Estimate record. Whether ICU Medical extends a record of beating EPS estimates in 8 of its last 8 reports.
• Related coverage. See our reports on WillScot, Teradata, Synaptics and Simon Property.

Sources: Results are from ICU Medical's Nov. 5, 2026 quarterly report. Estimates are consensus figures. The prior-quarter and year-ago comparison figures are from ICU Medical's earlier quarterly reports. Items labeled by our calculation are our own arithmetic. This article is informational only and is not investment advice.